Stock 688076 JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Equities

688076

CNE1000051X5

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
61.14 CNY +1.53% Intraday chart for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. +9.12% +36.02%
Apr. 22 Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd a China-based company principally engaged in the independent research and development and customized research and development and production of peptide drugs and small molecule drugs. The Company's main business includes customized product business and independently selected product business. Its customized product business includes CDMO (Contract Development and Manufacturing Organization) business, technical service CRO (Contract Research Organization) and transfer business. Its independently selected product business focuses on small molecule chemical drugs and conducts drug research and development in the key treatment areas of diabetes, cardiovascular diseases, tumors and other diseases. The Company mainly operates its businesses in the domestic market and overseas markets.

Number of employees: 1,545

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Manufacturing
100.0 %
651 100.0 % 1,034 100.0 % +58.69%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
56.7 %
284 43.8 % 585 56.7 % +106.19%
Overseas
43.3 %
364 56.2 % 447 43.3 % +22.86%

Managers

Managers TitleAgeSince
Zi Quan Tong CEO
 Chief Executive Officer 54 17-08-31
Wei Ding DFI
 Director of Finance/CFO 41 23-02-05
Biao Liu CHM
 Chairman 43 14-12-31
Mei Lü Sun BRD
 Director/Board Member 52 10-05-31
Guo Qiang Shi BRD
 Director/Board Member 63 19-05-19
Fu Qiang Jin BRD
 Director/Board Member 61 17-04-30
Le Er Wu IRC
 Investor Relations Contact - -
Hua Zhou SEC
 Corporate Secretary 46 23-02-05

Members of the board

Members of the board TitleAgeSince
Qiang Guo Xu BRD
 Director/Board Member 60 19-05-19
Feng Qu BRD
 Director/Board Member 49 19-05-19
De Yi Zhao BRD
 Director/Board Member 61 09-04-02
Fu Qiang Jin BRD
 Director/Board Member 61 17-04-30
Guo Qiang Shi BRD
 Director/Board Member 63 19-05-19
Zi Quan Tong CEO
 Chief Executive Officer 54 17-08-31
Wen Yan Hu BRD
 Director/Board Member 54 19-05-19
Biao Liu CHM
 Chairman 43 14-12-31
Mei Lü Sun BRD
 Director/Board Member 52 10-05-31
Xi Ping Qin BRD
 Director/Board Member 49 22-05-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 213,183,800 112,141,322 ( 52.60 %) 0 52.60 %

Shareholders

NameEquities%Valuation
Pan Family
13.37 %
19,124,494 13.37 % 140 M ¥
Zou Dan Chen
8.738 %
12,503,012 8.738 % 91 M ¥
China Merchants Fund Management Co., Ltd.
3.581 %
5,124,547 3.581 % 37 M ¥
Zhong Ou Asset Management Co., Ltd
2.466 %
3,528,951 2.466 % 26 M ¥
China Asset Management Co., Ltd.
1.503 %
2,150,000 1.503 % 16 M ¥
China Fund Management Co., Ltd.
1.237 %
1,770,000 1.237 % 13 M ¥
CIB Fund Management Co., Ltd.
1.070 %
1,530,801 1.070 % 11 M ¥
Fullgoal Fund Management Co., Ltd.
0.8003 %
1,145,066 0.8003 % 8 M ¥
Hwabao WP Fund Management Co., Ltd.
0.6397 %
915,297 0.6397 % 7 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.3056 %
437,224 0.3056 % 3 M ¥

Company contact information

Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

Room 1201, Building E Hangzhou Normal University Science

311121, Hangzhou

+

http://www.sinopep.com
address Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.(688076)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
61.14 CNY
Average target price
62.24 CNY
Spread / Average Target
+1.81%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. Stock Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
+36.02% 1.8B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688076 Stock
  4. Company Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW